drugset / Trial / NCT06368752

The Role of Endogenous GIP in Glycosis Metabolism During Fasting

NCT06368752 ↗

Phase 0 Unknown 12 enrolled Frederikke Koefoed-Hansen
RandomizedCrossoverDouble-blindBasic science

Summary

This research project aims to investigate the role of endogenous GIP during fasting. With the infusion of a GIP receptor antagonist (GIP\[3-30\]NH2), is it possible to selectively remove the effect of endogenous GIP, and thus describe its effects by comparing it with what happens during a saline infusion.

Timeline

Start
2023-05-04
Primary completion
2023-12-12
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject GIP(3-30)NH2 Unknown 800 unknown Intravenous

Indications